Target Name: Serine palmitoyltransferase
NCBI ID: P9223
Other Name(s): Long chain base biosynthesis protein | SPT | Serine-palmitoyl-CoA transferase | LCB 1

SPT: Synthesis Catalyst for Long Chain Base Proteins and Potential Drug Target

Serine palmitoyltransferase (SPT) is a protein that plays a crucial role in the synthesis of long chain base (LCB) proteins, which are involved in various cellular processes. Discovered in 1995, SPT is a member of the ATP-binding cassette (ABC) gene family, which includes proteins that are involved in the transfer of ATP to various cellular components. SPT is responsible for the synthesis of the last amino acid residue of LCBs, which is crucial for their functional integrity and stability.

SPT is a 23-kDa protein that is expressed in various tissues and cells, including muscle, heart, liver, and kidney. It is primarily localized to the endoplasmic reticulum (ER), where it is involved in the final step of the synthesis of LCBs. SPT is a critical regulator of LCB synthesis, as it ensures that the last amino acid residue of each LCB is added to the protein via a process called post-translational modification (PTM).

PTMs are a common mechanism by which proteins can be modified in the post-translational stage. These modifications can include phosphorylation, acetylation, Ubiquitination, and myristoylation, among others. SPT is involved in all of these PTMs, but its primary function is the addition of the last amino acid residue to LCBs.

SPT functions as a scaffold to facilitate the transfer of the last amino acid residue from the precursor amino acid to the target protein. It does this by interacting with several different components of the endoplasmic reticulum, including the transmembrane protein (TMP) and the protein kinase (PK) Kinase (PKC). TMP is a large transmembrane protein that is involved in the delivery of various proteins to the ER. PKC is a protein that is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

SPT interactions with TMP and PKC are critical for the efficient transfer of the last amino acid residue from the precursor amino acid to the target protein. TMP helps to transport SPT to the ER, where it can interact with PKC. PKC then phosphorylates SPT, which in turn facilitates the transfer of the last amino acid residue from the precursor amino acid to the target protein.

SPT is a protein that is involved in multiple cellular processes, including the regulation of protein synthesis, cell growth, and differentiation. It is also a potential drug target, as its dysfunction has been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

SPT has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, SPT has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the regulation of cancer cell growth and survival, which may contribute to its potential as a drug target.

In addition to its involvement in disease, SPT is also a potential drug target. Its dysfunction has been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Researchers are currently exploring the use of small molecules and other compounds to modulate SPT activity and treat various diseases.

In conclusion, Serine palmitoyltransferase (SPT) is a protein that plays a crucial role in the synthesis of long chain base (LCB) proteins. It is a critical regulator of LCB synthesis and is involved in multiple cellular processes, including the regulation of protein synthesis , cell growth, and differentiation. SPT is also a potential drug target, as its dysfunction has been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Further research is needed to fully understand the role of SPT in

Protein Name: Serine Palmitoyltransferase

More Common Targets

Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1 | SETD5 | SETD6 | SETD7 | SETD9 | SETDB1 | SETDB2 | SETMAR | SETP14 | SETP20 | SETP22 | SETX | SEZ6 | SEZ6L | SEZ6L2 | SF1 | SF3A1 | SF3A2 | SF3A3 | SF3A3P2 | SF3B1 | SF3B2 | SF3B3 | SF3B4 | SF3B5 | SF3B6 | SFI1 | SFMBT1 | SFMBT2 | SFN | SFPQ | SFR1 | SFRP1 | SFRP2 | SFRP4